更年期
医学
认知重构
激素疗法
疾病
老年学
激素替代疗法(女性对男性)
绝经后妇女
激素
妇科
外科更年期
梅德林
替代医学
重症监护医学
生理学
流行病学
作者
Laura L. Gravelsins,Mateja Perović,Madeline Wood Alexander,Tallinn F. L. Splinter,Andrew J. McGovern,Jennifer S. Rabin,Liisa A.M. Galea
出处
期刊:Science
[American Association for the Advancement of Science]
日期:2026-10-01
卷期号:394 (6819): 60-68
标识
DOI:10.1126/science.aeg5004
摘要
Menopause is an important biological transition with up to 72 symptoms that shapes aging trajectories across organs and encompasses ~40% of the female lifespan. Although menopause awareness is increasing, research on strategies for menopause symptom management and optimizing health in the postmenopausal period is lacking. This Review highlights that menopause characteristics, such as type, timing, and symptom burden, influence health outcomes and later-life disease risk. Similarly, menopause hormone therapy comes in >200 varieties that differ by dose, formulation of estrogens and progestogens, and timing, each with their own distinct risk-benefit profiles. These distinctions are often missed in the literature but have considerable repercussions for outcomes. Optimized menopause care necessitates a precision medicine approach that considers menopause symptoms, genetics, and previous hormone exposures.
科研通智能强力驱动
Strongly Powered by AbleSci AI